Home Authors Posts by Sarah Pringle

Sarah Pringle

Beecken Petty O’Keefe & Co. unloaded a majority of its investment in Medical Solutions in a deal valued around $500 million, Buyouts has learned. TPG Growth, TPG Capital’s middle-market and growth-equity arm, said May 8 it agreed to acquire the largest U.S. independent travel nurse staffing agency. Terms weren’t disclosed. The move follows a March Buyouts […]
Madison Dearborn Partners stands to make around 2.3x its money through the sale of VWR International, the lab-products distributor it first invested in nearly decade ago. The buyer is New Mountain Capital portfolio company Avantor, which said May 5 that it agreed to pay $33.25 cash per share for the Radnor, Pennsylvania, target. The agreement […]
Cortec Group is close to exiting its more than five-year investment in Cranial Technologies, the maker of helmets that treat infants with flat-head syndrome, according to four sources. The Tempe, Arizona, company generates roughly $12 million of EBITDA and $50 million of revenue, three sources said. Another private equity group has been selected as the […]
Physician-owned Allergy Partners is on the auction block, according to four sources. The company, considered the largest U.S. allergy and asthma practice group, has turned to Wells Fargo for financial advice, the sources said. Allergy Partners generates EBITDA in the low $20 million range and ought to command a double-digit multiple should the process produce […]
Northeast Dermatology Associates, one of the few independent dermatology groups of size that hasn’t already gained private equity backing, is exploring a sale, Buyouts has learned. The northern New England network of skin-treatment clinics is working with middle-market investment bank Browns Gibbons Lang, according to two sources familiar with the matter. Management meetings are getting […]
Bain & Company, Kara Murphy, private equity
Healthcare is poised to remain a safe-haven investment in 2017 as the sector’s long-term fundamentals remain positive, but the bar is rising as a growing number of funds disproportionately focus on the sector, according to Bain & Co Partner Kara Murphy. “The reality is [that] in a world where it’s so hard to get deals done, […]
Frontier Capital, Andrew Lindner, private equity
Employer-provided healthcare supports corporate wellness consolidation Frontier’s Viverae explores potential transactions PE firm eyes deals in RCM, cost-containment and tech supporting shift to value-based care Andrew Lindner is a co-founder and managing partner of Frontier Capital, where he helps lead the Charlotte, N.C., firm’s healthcare IT and vertical SaaS investment activities. Regardless of how the […]
For healthcare-focused private equity groups, specialization is more important than ever, panelists at ACG InterGrowth 2017 in Las Vegas emphasized this week. Opportunistically pursuing an asset at a below-market value is a strategy that no longer exists, especially as bulge-bracket firms increasingly compete for sub-$5-million EBITDA assets, said Enhanced Equity Funds principal Matthew Thompson on […]
American Securities, SpecialtyCare, medical services, healthcare, hospitals, private equity
SpecialtyCare, the American Securities-backed provider of intraoperative neuromonitoring and other emergency-room services, is in the midst of a sales process, according to four sources. Barclays is conducting the process, two sources said. The Nashville company generates about $55 million in EBITDA, two sources said. The target ought to fetch a multiple of roughly 10 times, […]
During Gores Group’s ownership of Fotona Holdings, the Slovenia medical-laser maker posted compound annual sales growth of about 23 percent while profitability nearly quadrupled, the firm’s managing director, Victor Otley, told Buyouts. Three-plus years after buying Fotona from the Slovenia government in a complex transaction, the firm unloaded its majority stake. The buyer is AGIC Capital, a Shanghai […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination